AI in Medicine — Cancer & Rare Disease — 2026-09-23 (Wed) Evening News
Source links point to the original outlet. The AI Integrated Analysis is auto-generated from the headlines below only and is not intended to add facts beyond them. Not investment advice.
Latest news on AI and rare and incurable diseases
Overview
In the diagnostic field, there are mainly presentations on AI pathology and genome mapping, and there are no headlines indicating specific progress in therapeutic drugs or systems. Several companies announced the construction of genetic analysis infrastructure (dataset preparation). There are no headings showing individual trends in the 348 designated intractable diseases.
Diagnosis of rare diseases
MGI announced its AI-enabled pathology portfolio “VisiOmics” in Europe at ECP 2026
News-Medical
. Numerical values showing diagnostic accuracy and shortened time to diagnosis are not listed in the headline and are unknown. Google DeepMind maps 9 billion DNA mutations and shows its potential for use in elucidating rare diseases
WION
. This is the construction of a mutation map, and does not indicate clinical application to cases or improvement in diagnostic rate.
Gene analysis/genome
Precure selects Helix to provide multi-omics testing and AI tools [Genetic Engineering and Biotechnology News]. Pure Genetic Medical and Breakthrough Genomics launch AI-powered “Virtual Geneticist”
Select Science
, There are no specific numerical values such as mutation determination accuracy in the heading. Tempus AI is also building a large-scale whole-genome multimodal dataset
Bitget
Yahoo Finance
. All of these are at the stage of developing research infrastructure and datasets, and are not reports that demonstrate clinical ability to interpret mutations. The Mainichi Keizai article reports that DeepMind used AI to pre-analyze and map the approximately 9 billion single-letter changes (single nucleotide mutations) in human DNA, and appears to be referring to the same initiative as WION's report.
Development of therapeutic drugs
No applicable information.
Nerve/muscular diseases
No applicable information.
Immunology/Collagen disease
No applicable information.
Rare metabolic/endocrine diseases
No applicable information.
System/Patient Support
No applicable information.
Japanese movements
It was reported that Anthropic will establish a biology research institute and begin full-scale AI drug discovery efforts.
Infoseek News
. The target disease/stage (pre-clinical or not, etc.) is not stated in the heading and is unknown. Mainichi Keizai (Korean media) has reported on DeepMind's mapping of DNA mutations, but it does not indicate the movements of systems and institutions in Japan.
Remarks from VIPs
No applicable information.
- AI framework improves rare disease diagnosis support in pediatric cases — AADC News09/09 19:07 UTC
- Hong Kong teen with rare disease creates AI avatar to ensure his story lives on — South China Morning Post09/13 07:00 UTC
- JAZZ: Record growth, new launches, and AI-driven strategies fuel rare disease expansion and raised outlook — TradingView09/10 16:47 UTC
- EXCLUSIVE: Anthropic quietly sets up biology lab as it ramps AI drug program — Reuters09/18 10:02 UTC
- “Anthropic” created a laboratory for biological experiments to use AI to find cures for rare diseases — Бабель09/18 12:30 UTC
- MGI launches VisiOmics in Europe and unveils AI-enabled pathology portfolio at ECP 2026 — News-Medical09/16 10:32 UTC
- Google DeepMind maps 9 billion DNA mutations: How AI could help solve rare diseases — WION09/09 07:00 UTC
- Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes — finance.yahoo.com09/19 11:14 UTC
- 3billion Accelerates Global Expansion of AI Variant Interpretation Platform — 3billion09/09 05:55 UTC
- Precure, LLC selects Helix as multi-omics lab and AI tools provider — Mayo Clinic News Network09/21 13:15 UTC
- Is Tempus AI (TEM) A Bargain After Its Whole Genome Research Platform Push? — simplywall.st09/15 00:24 UTC
- Tempus AI plans 100,000 whole genome sequencing dataset — Investing.com09/11 07:00 UTC
- Precure Selects Helix as Multiomics Lab and AI Tools Provider — Genetic Engineering and Biotechnology News09/21 15:09 UTC
- Pure Genetic Medical and Breakthrough Genomics introduces AI-powered Virtual Geneticist — Select Science09/17 04:56 UTC
- Ultima Genomics Selected to Generate One Million-Sample, World-Leading Multi-omic Biomedical Dataset for AI/ML Precure, LLC Initiative — PR Newswire09/22 12:00 UTC
- Tempus AI Building Multimodal Whole-Genome Dataset for AI Research — Bitget09/11 07:00 UTC
- Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation — Yahoo Finance09/11 07:00 UTC
- ACT Brief: Patient-Site Trust and AI Role, Platform Approach to Scale, Gene Therapy for Pediatric Disease — Applied Clinical Trials09/21 10:21 UTC
- Yan Leyfman։ AI-Enabled Standardization for Scalable Cell and Gene Therapy Trial Matching — Oncodaily09/22 20:10 UTC
- NIH backs AlphaRose's AI-designed therapy for ultra-rare Bain syndrome — Dealroom09/22 20:38 UTC
- AI is changing the talent biotech companies compete to hire — BioSpace09/16 07:01 UTC
- Anthropic establishes biology laboratory to focus on preclinical research on rare diseases - CHOSUNBIZ — Chosunbiz09/20 04:34 UTC
- Anthropic establishes biological research institute as AI drug development begins in earnest — ニューズウィーク日本版09/18 10:02 UTC
- [Karada/Kokoro Navi] 7% of patients use generated AI — 宮崎日日新聞09/11 07:00 UTC
- Anthropic establishes biological research institute as AI drug development ramps up in earnest | Infoseek News — Infoseek09/18 10:02 UTC
- What would happen to our bodies if one letter in our DNA changed? Google DeepMind used artificial intelligence (AI) to analyze the approximately 9 billion ``single-letter changes'' that can occur in human DNA and created a huge map. — 매일경제09/09 07:00 UTC
- Anthropic uses AI in biology laboratory for drug discovery — 日本経済新聞09/18 20:38 UTC
- US Anthropic establishes biology research institute to accelerate AI drug discovery (Business + IT) — Yahoo!ニュース09/18 13:30 UTC
- Anthropic secretly establishes wet laboratory, AI drug discovery ambitions shift from simulation to actual experiment — BigGo ファイナンス09/18 13:25 UTC
- Introducing a list of drug discovery and biotech stocks! Explanation of noteworthy investment points in AI drug discovery and regenerative medicine — 日本投資機構株式会社09/11 07:00 UTC
- Novo and Anthropic partner in drug discovery to shorten development time using AI — BigGo ファイナンス09/18 08:06 UTC